USD 0.01
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | -100.0% |
2022 | 100 Thousand USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
2010 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 FY | - USD | -100.0% |
2023 Q4 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | -100.0% |
2022 FY | 100 Thousand USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | 100 Thousand USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2011 Q1 | - USD | 0.0% |
2011 Q2 | - USD | 0.0% |
2011 Q3 | - USD | 0.0% |
2011 Q4 | - USD | 0.0% |
2011 FY | - USD | 0.0% |
2010 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
America Great Health | 204.3 Thousand USD | 100.0% |
Gene Biotherapeutics, Inc. | - USD | NaN% |
Evolutionary Genomics, Inc. | - USD | NaN% |
Innovation1 Biotech Inc. | - USD | NaN% |
Vicapsys Life Sciences, Inc. | - USD | NaN% |